Early surgery is recommended for mitral regurgitation

Circulation

Volumn 121, Issue 6, 2010, Pages 804-811

  Enriquez Sarano, Maurice ^a   Sundt, Thoralf M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE;

DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONAL REGULATION; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; MITRAL VALVE; MITRAL VALVE REGURGITATION; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

CARDIOVASCULAR SURGICAL PROCEDURES; HEALTH PLANNING GUIDELINES; HUMANS; MITRAL VALVE INSUFFICIENCY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77149139785     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.868083     Document Type: Review

References (52)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-1011.
2. Suri RM, Schaff HV, Dearani JA, Sundt TM III, Daly RC, Mullany CJ, Enriquez-Sarano M, Orszulak TA. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg. 2006;82:819-826.
3. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382-1394.
4. Enriquez-Sarano M, Loulmet DF, Burkhoff D. The conundrum of functional mitral regurgitation in chronic heart failure. J Am Coll Cardiol. 2008;51:487-489.
5. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84-e231.
6. Tribouilloy C, Enriquez-Sarano M, Schaff H, Orszulak T, Bailey K, Tajik A, Frye R. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation. 1999;99:400-405.
7. Enriquez-Sarano M, Tajik A, Schaff H, Orszulak T, Bailey K, Frye R. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994;90:830-837
8. Gammie JS, O'Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007;115:881-887.
9. Ling H, Enriquez-Sarano M, Seward J, Tajik A, Schaff H, Bailey K, Frye R. Clinical outcome of mitral regurgitation due to flail leaflets. N Eng J Med. 1996;335:1417-1423.
10. Bridgewater B, Hooper T, Munsch C, Hunter S, von Oppell U, Livesey S, Keogh B, Wells F, Patrick M, Kneeshaw J, Chambers J, Masani N, Ray S. Mitral repair best practice: proposed standards. Heart. 2006;92:939-944.
11. Kang DH, Kim JH, Rim JH, Kim MJ, Yun SC, Song JM, Song H, Choi KJ, Song JK, Lee JW. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation. 2009; 119:797-804.
12. Rosenhek R, Rader F, Klaar U, Gabriel H, Krejc M, Kalbeck D, Schemper M, Maurer G, Baumgartner H. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113:2238-2244.
13. Avierinos JF, Inamo J, Grigioni F, Gersh B, Shub C, Enriquez-Sarano M. Sex differences in morphology and outcomes of mitral valve prolapse. Ann Intern Med. 2008;149:787-795.
14. Grigioni F, Tribouilloy C, Avierinos JF, Barbieri A, Ferlito M, Trojette F, Tafanelli A, Branzi A, Szymanski C, Habib G, Modena MG, Enriquez-Sarano M. Outcomes in mitral regurgitation due to flail leaflets. J Am Coll Cardiol Img. 2008;1:133-141.
15. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005; 352:875-883. (Pubitemid 40300296)
16. Bech-Hanssen O, Ryden T, Schersten H, Oden A, Nilsson F, Jeppsson A. Mortality after mitral regurgitation surgery: importance of clinical and echocardiographic variables. Eur J Cardiothorac Surg. 2003;24:723-730.
17. David TE, Ivanov J, Armstrong S, Rakowski H. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J Thorac Cardiovasc Surg. 2003;125:1143-1152.
18. Lee EM, Shapiro LM, Wells FC. Mortality and morbidity after mitral valve repair: the importance of left ventricular dysfunction. J Heart Valve Dis. 1995;4:460-468.
19. Crawford M, Souchek J, Oprian C, Miller D, Rahimtoola S, Giacomini J, Sethi G, Hammermeister K. Determinants of survival and left ventricular performance after mitral valve replacement. Circulation. 1990;81: 1173-1181.
20. David TE, Ivanov J, Armstrong S, Christie D, Rakowski H. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J Thorac Cardiovasc Surg. 2005;130: 1242-1249.
21. Suri RM, Schaff HV, Dearani JA, Sundt TM, Daly RC, Mullany CJ, Enriquez-Sarano M, Orszulak TA. Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse. J Thorac Cardiovasc Surg. 2009;137:1071-1076.
22. Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C, Ferlito M, Tafanelli A, Bursi F, Trojette F, Branzi A, Habib G, Modena MG, Enriquez-Sarano M. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets: a long-term follow-up multicenter study. J Am Coll Cardiol. 2009;54:1961-1968.
23. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgita-tion. Circulation. 1995;91:1022-1028.
24. Detaint D, Sundt TM, Nkomo VT, Scott CG, Tajik AJ, Schaff HV, Enriquez-Sarano M. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation. 2006;114:265-272.
25. Jokinen JJ, Hippelainen MJ, Pitkanen OA, Hartikainen JE. Mitral valve replacement versus repair: propensity-adjusted survival and quality-of-life analysis. Ann Thorac Surg. 2007;84:451-458.
26. Shuhaiber J, Anderson RJ. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg. 2007;31:267-275.
27. Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA, Enriquez-Sarano M. Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation. 2001;104(suppl):I-1-I-7.
28. Russo A, Grigioni F, Avierinos JF, Freeman WK, Suri R, Michelena H, Brown R, Sundt TM, Enriquez-Sarano M. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am Coll Cardiol. 2008;51:1203-1211.
29. Gillinov A, Cosgrove D, Blackstone E, Diaz R, Arnold J, Lytle B, Smedira N, Sabik J, McCarthy P, Loop F. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 1998;116:734-743.
30. Flameng W, Herijgers P, Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation. 2003;107:1609-1613.
31. Suri RM, Schaff HV, Dearani JA, Sundt TM III, Daly RC, Mullany CJ, Enriquez-Sarano M, Orszulak TA. Recurrent mitral regurgitation after repair: should the mitral valve be re-repaired? J Thorac Cardiovasc Surg. 2006;132:1390-1397.
32. Gillinov AM, Blackstone EH, Nowicki ER, Slisatkorn W, Al-Dossari G, Johnston DR, George KM, Houghtaling PL, Griffin B, Sabik JF III, Svensson LG. Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg. 2008;135:885-893, e881-e882.
33. McClure RS, Cohn LH, Wiegerinck E, Couper GS, Aranki SF, Bolman RM III, Davidson MJ, Chen FY. Early and late outcomes in minimally invasive mitral valve repair: an eleven-year experience in 707 patients. J Thorac Cardiovasc Surg. 2009;137:70-75.
34. Seeburger J, Borger MA, Falk V, Kuntze T, Czesla M, Walther T, Doll N, Mohr FW. Minimal invasive mitral valve repair for mitral regurgita-tion: results of 1339 consecutive patients. Eur J Cardiothorac Surg. 2008;34:760-765.
35. Grigioni F, Enriquez-Sarano M, Ling L, Bailey K, Seward J, Tajik A, Frye R. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34:2078-2085.
36. Avierinos JF, Gersh BJ, Melton LJ III, Bailey KR, Shub C, Nishimura RA, Tajik AJ, Enriquez-Sarano M. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106:1355-1361.
37. Pizarro R, Bazzino OO, Oberti PF, Falconi M, Achilli F, Arias A, Krauss JG, Cagide AM. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol. 2009;54:1099-1106.
38. Rosen SE, Borer JS, Hochreiter C, Supino P, Roman MJ, Devereux RB, Kligfield P, Bucek J. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol. 1994;74:374-380.
39. Krauss J, Pizarro R, Oberti PF, Falconi M, Cagide A. Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with chronic organic mitral regurgitation and normal left ventricular performance. Am Heart J. 2006;152:1004 e1001-e1008.
40. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanover-schelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358-1365.
41. Bach DS, Awais M, Gurm HS, Kohnstamm S. Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol. 2009;54:860-865.
42. Grigioni F, Avierinos JF, Ling LH, Scott CG, Bailey KR, Tajik AJ, Frye RL, Enriquez-Sarano M. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002;40:84-92.
43. Messika-Zeitoun D, Bellamy M, Avierinos JF, Breen J, Eusemann C, Rossi A, Behrenbeck T, Scott C, Tajik JA, Enriquez-Sarano M. Left atrial remodelling in mitral regurgitation-methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study. Eur Heart J. 2007;28:1773-1781.
44. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ. Evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography: a report from the Task Force on Valvular Regurgitation of the American Society of Echocardiography. J Am Soc Echocardiogr. 2003;16:777-802.
45. Enriquez-Sarano M, Basmadjian A, Rossi A, Bailey K, Seward J, Tajik A. Progression of mitral regurgitation: a prospective Doppler echocardio-graphic study. J Am Coll Cardiol. 1999;34:1137-1144.
46. Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC Jr, Enriquez-Sarano M. B-type natriuretic peptide in organic mitral re-gurgitation: determinants and impact on outcome. Circulation. 2005;111: 2391-2397.
47. Messika-Zeitoun D, Johnson BD, Nkomo V, Avierinos JF, Allison TG, Scott C, Tajik AJ, Enriquez-Sarano M. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol. 2006;47:2521-2527.
48. Dujardin KS, Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ. Effect of losartan on degree of mitral regurgitation quantified by echo-cardiography. Am J Cardiol. 2001;87:570-576.
49. Nemoto S, Hamawaki M, De Freitas G, Carabello BA. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol. 2002;40:149-154.
50. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, St Goar F, Rodriguez L, Silvestry F, Schwartz A, Sanborn TA, Condado JA, Foster E. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol. 2005;46:2134-2140.
51. Ling L, Enriquez-Sarano M, Seward J, Orszulack T, Schaff H, Bailey K, Tajik A, Frye R. Early surgery in patients with mitral regurgitation due to partial flail leaflet: a long-term outcome study. Circulation. 1997;96: 1819-1825.
52. Ray S, Chambers J, Gohlke-Baerwolf C, Bridgewater B. Mitral valve repair for severe mitral regurgitation: the way forward? Eur Heart J. 2006;27:2925-2928.